Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
This article discusses platelet active drugs as part of the Seventh American College of Chest
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based
Guidelines. New data on antiplatelet agents include the following:(1) the role of aspirin in
primary prevention has been the subject of recommendations based on the assessment of
cardiovascular risk;(2) an increasing number of reports suggest a substantial interindividual
variability in the response to antiplatelet agents, and various phenomena of “resistance” to …
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based
Guidelines. New data on antiplatelet agents include the following:(1) the role of aspirin in
primary prevention has been the subject of recommendations based on the assessment of
cardiovascular risk;(2) an increasing number of reports suggest a substantial interindividual
variability in the response to antiplatelet agents, and various phenomena of “resistance” to …